At the request of IRLAB Therapeutics AB (publ), 556931-4692, IRLAB Therapeutics AB A-shares will be traded on First North Premier as from February 28, 2017. The decision is conditional upon that IRLAB Therapeutics AB can meet the requirements regarding liquidity.
The company has 6,999,939 shares as per today’s date (6,928,388 A-shares and 71,551 B-shares).
| Short name: | IRLAB A |
| Number of shares to be listed: | 6,928,388 |
| ISIN code: | SE0009242225 |
| Round Lot: | 1 |
| Order book ID: | 132776 |
| ADT Value: | 4,000,000 |
| Company Registration Number: | 556931-4692 |
| Market segment: | First North STO/8 |
| Tick Size table: | Other Equities |
| MIC code: | FNSE |
| Trading currency: | SEK |
Classification
| Code | Name |
| 4000 | Health Care |
| 4500 | Health Care |
This information is distributed at the request of the Certified Adviser, FNCA Sweden AB. For further information, please call FNCA Sweden AB on +46 (0) 8 528 00 399.